Prime Medicine Statistics
NASDAQ: PRMEHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
3.90+0.40 (+11.43%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 3.85 -1.34%
Prime Medicine by the numbers
Prime Medicine has a market capitalization of $707.4 million based on 181.38M shares outstanding. With trailing EPS of $-1.07, Prime Medicine is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 20.5% above its 50-day average and 12.2% above its 200-day average.
Average daily trading volume is 3.32M shares, or about $12.9 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
PRME valuation vs. peer median
| Metric | PRME | Peer median | Difference |
|---|---|---|---|
| Market cap | $707.37M | $648.32M | +9% |
| Avg. volume | 3.32M | 836.05K | +297% |
Peer median across 8 companies: PROK, DBVT, AURA, ETRA, FDMT, VALN, SLDB, ATTO.
Valuation
- Market cap
- $707.37M
- EPS (TTM)
- $-1.07
- Shares outstanding
- 181.38M
Price and trading
- Previous close
- 3.50
- Open
- 3.32
- Day range
- 3.30 – 4.02
- 52-week range
- 2.67 – 6.85
- 52-week change
- -33.56%
- Beta
- —
- Volume
- 11.16M
- Average volume
- 3.32M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 6, 2026
Additional statistics
- Market Cap
- 707.37M
- Forward Pe
- -4.39
- Eps
- -1.07
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 6.85
- Week52 Low
- 2.67
- Avg Volume
- 3.32M
- Shares Outstanding
- 181.38M
- Ma50
- 3.24
- Ma200
- 3.48
- Earnings Date
- Nov 6, 2026
- Pct From52w High
- -43.07%
- Pct From52w Low
- 46.07%